| Office of Health Economics
Secretary General | European Patients Forum (EPF), Brussels, Belgium
Felix Lobo, PhD
Emeritus Professor of Economics | University Carlos III de Madrid, Madrid, Spain
Managing Director, Science & Policy Consultancy. Professor in Health Services Research and HTA at Department of Public Health Research Unit of User Perspectives, | University of Southern Denmark, and External Lecturer at Copenhagen Business School, Department of Strategy and Innovation, Denmark
Director, Health Systems, Medical Products and Innovation, Directorate General | Health and Food Safety (DG SANTE), European Commission, Belgium
Head, HTA & Payment Policy, Global Pricing & Market Access (GPMA) | F. Hoffmann-La Roche AG, Basel, Switzerland
Eric Low, OBE
Head of Global Strategy | Amyloidosis Research Consortium, East Lothian, Scotland, UK
Geert van Maanen
Former Secretary-General | Ministry of Health, Welfare and Sport, The Netherlands
Guillem López-Casasnovas, PhD
Professor | Department of Economics and Founder & Director, Center for Health and Economics, Universitat Pompeu Fabra, Barcelona, Spain
Chief Financial Officer | PureTech Health, Boston, MA, USA
Lluis Sauri-Romero
Economist | DG Competition, European Commission, Brussels, Belgium
Clinical Government Service Director, HTA | Azienda USL di Modena, Regione Emilia Romagna Bologna, Italy
Head, Department of Pharmacoeconomics, Institute of Mother and Child, and Business School, Warsaw University of Technology, Warsaw, Poland | Former Undersecretary of State/Vice Minister, Polish Ministry of Health, Poland
Menno Aarnout
Executive Director | International Association of Mutual Benefit Societies (AIM), Brussels, Belgium
Peter C. Smith, MSc
Emeritus Professor of Health Policy | Imperial College Business School and Professor of Global Health Economics, Centre for Health Economics, University of York, London, UK
Richard Torbett, PhD
Executive Director | Commercial Policy - UK and International, The Association of the British Pharmaceutical Industry (ABPI) and Chair, Pricing & Reimbursement Priority Working Group, EFPIA, London, UK
Roman Topór-Mądry
President | Agency for Health Technology Assessment at Tariff System (AOTMiT), Warsaw, Poland
Sarah Garner, PhD
Coordinator | Innovation, Access and Use, Essential Medicines and Health Products Department, World Health Organization (WHO), Geneva, Switzerland
Director | Policy and Economic Analysis, Patented Medicine Prices Review Board (PMPRB), Government of Canada, Ottawa, Canada
Professor of Health Economics & Director of the Centre for Health Policy | University of Melbourne, Melbourne, Victoria, Australia
Founder and CEO | ExPPect
Research Scientist | Google
Research Programme Officer | EU Policies, Unit H3, eHealth, Well-being & Ageing, DG CONNECT, Communications Networks, Content and Technology, European Commission, Brussels, Belgium
Executive Director | Blue Spoon Consulting, New York, New York
Clinical Data Scientist | Erasmus University Medical Centre, Rotterdam, Associate Dean, Permanent Education for Professionals, Jheronimus Academy of Data Science, Rotterdam, The Netherlands
Co-Founder, CML Advocates Network and Founder and CEO, Patvocates, EUPATI, Munich, Germany |
Vice President, Real-World & Late Phase | Syneos Health, Toronto, Canada
Head of Sector, HTA, Directorate General | Health and Food Safety (DG SANTE), European Commission